Recent News About Glaxosmithkline Llc
-
SCOTUS ruling changed "approach" to drug labeling questions, plaintiffs said. GSK says the change wasn't "extraordinary" enough and would open "floodgates" to attempts at lawsuit "do-overs."
-
The widow of a lawyer who took his own life, allegedly after taking the generic equivalent of widely prescribed antidepressant drug, Paxil, will not get a chance to undo a federal appeals court’s decision to toss out a federal jury’s findings that GSK, the maker of Paxil, owes her $3 million because it allegedly didn’t push federal regulators hard enough to revise the drug’s warning label.
-
Asserting a Chicago federal appeals panel wrongly invalidated a jury’s verdict, attorneys for the widow of a Chicago lawyer who committed suicide after taking the generic version of the antidepressant drug Paxil, have asked the U.S. Supreme Court to throw out the appellate ruling and order more proceedings on whether pharmaceutical company GlaxoSmithKline should be made to pay for allegedly not revising their drug’s warning label to reflect an increased risk of suicide.
